Pathways to economically viable and sustainable vaccine manufacturing in LMICs

Key Points

• Sustainable vaccine manufacturing is vital for low- and middle-income countries (LMICs), increasing access and immunization rates.
• The analysis highlights the importance of cost-effectiveness, fostering economic viability in these nations.
• Assessment across multiple LMICs identifies key production pathways and innovative biotechnological approaches.
• Highlights the need for collaboration in technology transfer to ensure sustainable production and economic growth.